Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4632]

Personalised therapy reduces cancer risk for diabetes patients

Personalised therapy reduces cancer risk for diabetes patients

Nivolumab approved by FDA for recurrent head and neck cancer

Nivolumab approved by FDA for recurrent head and neck cancer

DNA sequencing determines lymphoma origin, prognosis

DNA sequencing determines lymphoma origin, prognosis

Patient-derived tumour xenograft models for ovarian cancer are suitable for future epigenetic methylome-based cancer research

Patient-derived tumour xenograft models for ovarian cancer are suitable for future epigenetic methylome-based...

Genetically engineering disease-fighting cells

Genetically engineering disease-fighting cells

NCRI 2016: Marker for aggressive prostate cancer doubles as a drug target

NCRI 2016: Marker for aggressive prostate cancer doubles as a drug target

Tailored, dense-dose chemotherapy for early breast cancer does not result in significant improvement

Tailored, dense-dose chemotherapy for early breast cancer does not result in significant improvement

Potential targeted therapy found for newly identified leukaemia subtype with poor outcome

Potential targeted therapy found for newly identified leukaemia subtype with poor outcome

Checkpoint blockade helps only a subset of patients, why?

Checkpoint blockade helps only a subset of patients, why?

Scientists discover a cause of multiple resistance to cancer chemotherapy

Scientists discover a cause of multiple resistance to cancer chemotherapy

More from ecancer